268 related articles for article (PubMed ID: 31704102)
1. Plasma trimethylamine N-oxide, a gut microbe-generated phosphatidylcholine metabolite, is associated with autism spectrum disorders.
Quan L; Yi J; Zhao Y; Zhang F; Shi XT; Feng Z; Miller HL
Neurotoxicology; 2020 Jan; 76():93-98. PubMed ID: 31704102
[TBL] [Abstract][Full Text] [Related]
2. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
[TBL] [Abstract][Full Text] [Related]
3. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand.
Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Tatsanavivat P; Sritara P; Phrommintikul A
Sci Rep; 2021 Jul; 11(1):14963. PubMed ID: 34294762
[TBL] [Abstract][Full Text] [Related]
5. Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population.
Zheng L; Zheng J; Xie Y; Li Z; Guo X; Sun G; Sun Z; Xing F; Sun Y
Atherosclerosis; 2019 Jan; 280():126-131. PubMed ID: 30508691
[TBL] [Abstract][Full Text] [Related]
6. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
[TBL] [Abstract][Full Text] [Related]
7. Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke.
Sun T; Zhang Y; Yin J; Peng X; Zhou L; Huang S; Wen Y; Cao B; Chen L; Li X; Yang W; Tan A; Cheng J; Liu L
J Atheroscler Thromb; 2021 Apr; 28(4):320-328. PubMed ID: 32641646
[TBL] [Abstract][Full Text] [Related]
8. [Distribution characteristics of trimethylamine N-oxide and its association with gut microbiota].
Wang S; Xia GH; He Y; Liao SX; Yin J; Sheng HF; Zhou HW
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):455-60. PubMed ID: 27113169
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
10. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
11. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.
Senthong V; Li XS; Hudec T; Coughlin J; Wu Y; Levison B; Wang Z; Hazen SL; Tang WH
J Am Coll Cardiol; 2016 Jun; 67(22):2620-8. PubMed ID: 27256833
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma levels of glutamate in children with autism spectrum disorders.
Cai J; Ding L; Zhang JS; Xue J; Wang LZ
Neuroreport; 2016 Mar; 27(4):272-6. PubMed ID: 26825346
[TBL] [Abstract][Full Text] [Related]
13. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury.
Wu C; Xue F; Lian Y; Zhang J; Wu D; Xie N; Chang W; Chen F; Wang L; Wei W; Yang K; Zhao W; Wu L; Song H; Ma Q; Ji X
Neurology; 2020 Feb; 94(7):e667-e677. PubMed ID: 31907287
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of SOD and risk of autism spectrum disorder: A case-control study.
Wang L; Jia J; Zhang J; Li K
Int J Dev Neurosci; 2016 Jun; 51():12-6. PubMed ID: 27091401
[TBL] [Abstract][Full Text] [Related]
15. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
16. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
17. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke.
Hou L; Zhang Y; Zheng D; Shi H; Zou C; Zhang H; Lu Z; Du H
Neurol Res; 2020 Feb; 42(2):153-158. PubMed ID: 31928326
[No Abstract] [Full Text] [Related]
18. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.
Zhuang R; Ge X; Han L; Yu P; Gong X; Meng Q; Zhang Y; Fan H; Zheng L; Liu Z; Zhou X
Obes Rev; 2019 Jun; 20(6):883-894. PubMed ID: 30868721
[TBL] [Abstract][Full Text] [Related]
19. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-
Cho CE; Aardema NDJ; Bunnell ML; Larson DP; Aguilar SS; Bergeson JR; Malysheva OV; Caudill MA; Lefevre M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722424
[TBL] [Abstract][Full Text] [Related]
20. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
